NDC 83616-106 – Tudriqev

Vusolimogene Oderparepvec 1000000 [PFU]/mL · Injection, Suspension · Intratumor

Human Prescription Drug

Product NDC83616-106

Product details

Brand name
Tudriqev
Generic name
Vusolimogene oderparepvec-wtpg
Labeler
Replimune, Inc.
Dosage form
Injection, Suspension
Route
Intratumor
Marketing category
BLA · BLA125827
Marketed since
September 4, 2026
Listing expires
December 31, 2027

Active ingredients

Package NDC codes (1)

Package NDCDescriptionSince
83616-106-111 VIAL, SINGLE-DOSE in 1 CARTON (83616-106-11) / 1 mL in 1 VIAL, SINGLE-DOSE (83616-106-01)Sep 4, 2026

Other Tudriqev products